Granata Guido, Schiavone Francesco, Pipitone Giuseppe, Taglietti Fabrizio, Petrosillo Nicola
Clinical and Research Department for Infectious Diseases, National Institute for Infectious Diseases L. Spallanzani, IRCCS, 00149 Rome, Italy.
Divers and Raiders Group Command "Teseo Tesei" COMSUBIN, Medical Service, Italian Navy, 19025 Portovenere, Italy.
J Clin Med. 2022 Dec 4;11(23):7207. doi: 10.3390/jcm11237207.
The issue of bacterial infections in COVID-19 patients has received increasing attention among scientists. Antibiotics were widely prescribed during the early phase of the pandemic. We performed a literature review to assess the reasons, evidence and practices on the use of antibiotics in COVID-19 in- and outpatients. Published articles providing data on antibiotics use in COVID-19 patients were identified through computerized literature searches on the MEDLINE and SCOPUS databases. Searching the MEDLINE database, the following search terms were adopted: ((antibiotic) AND (COVID-19)). Searching the SCOPUS database, the following search terms were used: ((antibiotic treatment) AND (COVID-19)). The risk of bias in the included studies was not assessed. Both quantitative and qualitative information were summarized by means of textual descriptions. Five-hundred-ninety-three studies were identified, published from January 2020 to 30 October 2022. Thirty-six studies were included in this systematic review. Of the 36 included studies, 32 studies were on the use of antibiotics in COVID-19 inpatients and 4 on antibiotic use in COVID-19 outpatients. Apart from the studies identified and included in the review, the main recommendations on antibiotic treatment from 5 guidelines for the clinical management of COVID-19 were also summarized in a separate paragraph. Antibiotics should not be prescribed during COVID-19 unless there is a strong clinical suspicion of bacterial coinfection or superinfection.
新冠病毒感染患者的细菌感染问题日益受到科学家的关注。在疫情早期,抗生素被广泛使用。我们进行了一项文献综述,以评估新冠病毒感染住院和门诊患者使用抗生素的原因、证据及实践情况。通过对MEDLINE和SCOPUS数据库进行计算机化文献检索,确定了提供新冠病毒感染患者抗生素使用数据的已发表文章。在检索MEDLINE数据库时,采用了以下检索词:((抗生素)AND(新冠病毒感染))。在检索SCOPUS数据库时,使用了以下检索词:((抗生素治疗)AND(新冠病毒感染))。未评估纳入研究的偏倚风险。通过文字描述对定量和定性信息进行了总结。共识别出593项研究,发表时间为2020年1月至2022年10月30日。本系统综述纳入了36项研究。在这36项纳入研究中,32项研究涉及新冠病毒感染住院患者使用抗生素的情况,4项研究涉及新冠病毒感染门诊患者使用抗生素的情况。除了本综述中识别和纳入的研究外,还在单独一段中总结了5份新冠病毒感染临床管理指南中关于抗生素治疗的主要建议。除非有强烈的临床怀疑存在细菌合并感染或二重感染,否则在新冠病毒感染期间不应使用抗生素。